2017 Press Releases

EXTON, Pa. , Aug. 23, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at three investor conferences in

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 26, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2018 and reaffirmed financial guidance for full-year 2018.  Executive Summary Second-quarter

EXTON, Pa. , July 19, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the official opening of its new Waterford, Ireland facility, a global center of excellence for West's advanced

EXTON, Pa. , July 12, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2018 financial results before the market opens on Thursday, July 26, 2018 ,

EXTON, Pa. , June 21, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed Bernard J. Birkett to serve as Senior Vice President, Chief Financial Officer and Treasurer,

EXTON, Pa. , June 13, 2018 /PRNewswire/ -- (Booth #1933) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it has received the Silver Medical Design Excellence Award for "Drug-Delivery and Combination

EXTON, Pa. , May 24, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at two investor conferences in June.

EXTON, Pa. , May 3, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2018 dividend of $0.14 per share.  The dividend will be paid on August 1, 2018 , to shareholders of record as of July 18, 2018

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2018 and reaffirmed financial guidance for full-year 2018.  Executive Summary First-quarter 2018

EXTON, Pa. , April 12, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2018 financial results before the market opens on Thursday, April 26, 2018 ,

West to present several scientific posters highlighting expertise in ensuring quality, sterility and stability of injectable drug products ORLANDO, Fla. , March 19, 2018 /PRNewswire/ -- (Booth #501) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for

EXTON, Pa. , March 2, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced William Federici , Senior Vice President, Chief Financial Officer and Treasurer, has communicated his intention to

EXTON, Pa. , Feb. 26, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced Silji Abraham has been appointed Senior Vice President and Chief Digital and Transformation Officer, and will be

- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 15, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2017 and provided financial guidance for full-year 2018.  Executive Summary

West Pharmaceutical Services, Inc. to showcase SelfDose injector among other advancements in integrated containment and drug delivery at Pharmapack Europe 2018 PARIS , Feb. 7, 2018 /PRNewswire/ -- Booth #D20 -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions

EXTON, Pa. , Feb. 1, 2018 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2017 financial results before the market opens on Thursday,

EXTON, Pa. , Dec. 22, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2018 dividend of $0.14 per share. The dividend will be paid on February 1, 2018 , to shareholders of record as of January 18,

EXTON, Pa. , Nov. 15, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that management will be presenting a West business overview at the upcoming Jefferies 2017 London Healthcare Conference ,

Company will Lead Educational Sessions and Share Scientific Advances in Integrated Containment and Drug Delivery VIENNA , Nov. 6, 2017 /PRNewswire/ --  (Booth X67) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 26, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2017, updated financial guidance for the full-year 2017, introduced sales growth outlook for

EXTON, Pa. , Oct. 12, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2017 financial results before the market opens on Thursday, October 26, 2017 ,

EXTON, Pa. , Oct. 10, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today shared the results of a study highlighting the benefits of West's ID Adapter for improving the intradermal administration of

EXTON, Pa. , Aug. 25, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that management will be presenting a West business overview at three investor conferences in September.

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 27, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2017 and updated financial guidance for the full-year 2017.

West to Host Second-Quarter 2017 Conference Call EXTON, Pa. , July 20, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has approved a fourth-quarter

EXTON, Pa. , June 1, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors elected Deborah Keller as its newest member. With the addition of Ms. Keller, West's Board of Directors increases in size to 11 directors. Ms.

Presentation caps week-long series of educational seminars throughout India sharing scientific insights and best practices in drug containment and delivery for injectable biologics EXTON, Pa. , May 30, 2017 /PRNewswire/ -- (Booth #B-3) -- West Pharmaceutical Services, Inc.

EXTON, Pa. , May 15, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2017 dividend of $0.13 per share. The dividend will be paid on August 2, 2017 to shareholders of record as of July 19, 2017 .

EXTON, Pa. , May 3, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that Fran DeGrazio , Vice President Scientific Affairs and Technical Services, and Diane Paskiet , Director,

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 27, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2017 and updated financial guidance for the full-year 2017.  First-Quarter 2017 Highlights

EXTON, Pa. , April 13, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2017 financial results before the market opens on Thursday, April 27, 2017 ,

- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 16, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2016 and provided detailed financial guidance for full-year 2017.  Executive

EXTON, Pa. , Feb. 2, 2017 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2016 financial results before the market opens on Thursday,

Scientific and educational sessions to feature West's innovation and regulatory expertise EXTON, Pa. , Feb. 1, 2017 /PRNewswire/ -- Booth #H26 -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today introduced two new

EXTON, Pa. , Dec. 28, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of the Company's business at the 35 th Annual J.P. Morgan Healthcare Conference , San Francisco, CA , at 3:30 p.m.

Flynn recognized in the Female Executive of the Year category for her instrumental role in developing and executing West's market-led, long-term strategic plan EXTON, Pa. , Dec. 20, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for

Company honored with 2016 India Pharma Award and Irish Medtech Excellence Award; West's SmartDose® platform takes second place in Medicine Maker Innovation Awards EXTON, Pa. , Dec. 15, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for

EXTON, Pa. , Dec. 14, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2017 dividend of $0.13 per share. The dividend will be paid on February 1, 2017 , to shareholders of record as of January 18,

Adds to Growing Manufacturing Footprint in Ireland DUBLIN , Nov. 29, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the completion of a 60,000 square foot expansion at its contract

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 27, 2016 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter 2016, updated financial guidance for the full-year 2016, introduced sales growth outlook for